KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Non Operating Income (2017 - 2025)

Twist Bioscience (TWST) has disclosed Non Operating Income for 9 consecutive years, with $471000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 606.45% to $471000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$196000.0 through Dec 2025, up 92.85% year-over-year, with the annual reading at -$903000.0 for FY2025, 66.29% up from the prior year.
  • Non Operating Income for Q4 2025 was $471000.0 at Twist Bioscience, up from $420000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $471000.0 in Q4 2025, with the low at -$2.3 million in Q3 2024.
  • Average Non Operating Income over 5 years is -$300950.0, with a median of -$212000.0 recorded in 2022.
  • The sharpest move saw Non Operating Income tumbled 1768.42% in 2021, then surged 606.45% in 2025.
  • Over 5 years, Non Operating Income stood at -$156000.0 in 2021, then fell by 0.64% to -$157000.0 in 2022, then soared by 80.25% to -$31000.0 in 2023, then plummeted by 200.0% to -$93000.0 in 2024, then soared by 606.45% to $471000.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $471000.0, $420000.0, and -$836000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.